Ugandan health authorities are set to begin an Ebola vaccine trial after new outbreak kills a nurse Ugandan officials are preparing to deploy a trial vaccine as part of efforts to stem an outbreak of Ebola in the capital, Kampala, a top health official said Sunday.
A range of scientists are developing research protocols relating to the planned deployment of more than 2,000 doses of a candidate vaccine against the Sudan strain of Ebola, said Pontiano Kaleebu, executive director of Uganda Virus Research Institute.
Uganda has had access to candidate vaccine doses since the end of an Ebola outbreak in September 2022 that killed at least 55 people.
A trial vaccine known as rVSV-ZEBOV, used to vaccinate 3,000 people at risk of infection during an outbreak of the Zaire strain of Ebola in eastern Congo between 2018 and 2020, proved effective in containing the spread of the disease there.
The World Health Organization said in a statement that its support to Uganda’s response to the outbreak includes access to 2,160 doses of trial vaccine.
